Cargando…

Improving communication with multiple sclerosis patients

Detalles Bibliográficos
Autor principal:	Alroughani, Raed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Riyadh : Armed Forces Hospital 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727647/ https://www.ncbi.nlm.nih.gov/pubmed/25864060 http://dx.doi.org/10.17712/nsj.2015.2.20140441

Ejemplares similares

Pediatric multiple sclerosis: a review
por: Alroughani, Raed, et al.
Publicado: (2018)

Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
por: Alroughani, Raed, et al.
Publicado: (2017)

The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients
por: Al-Serri, Ahmad, et al.
Publicado: (2019)

Status migrainosus as an initial presentation of multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2015)

Replication analysis of variants associated with multiple sclerosis risk
por: Dashti, Mohammad, et al.
Publicado: (2020)

Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
por: Alroughani, Raed, et al.
Publicado: (2016)

A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
por: El-Muzaini, Hadeel, et al.
Publicado: (2020)

Economic burden of multiple sclerosis on Kuwait health care system
por: Alowayesh, Maryam S., et al.
Publicado: (2019)

Correction to: A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
por: El-Muzaini, Hadeel, et al.
Publicado: (2020)

Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis care
por: Salama, Sara, et al.
Publicado: (2020)

Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study
por: Akhtar, Saeed, et al.
Publicado: (2023)

Spinal segmental myoclonus as an unusual presentation of multiple sclerosis
por: Alroughani, Raed Abdullah, et al.
Publicado: (2015)

COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
por: Alroughani, Raed, et al.
Publicado: (2022)

Association of Multiple Sclerosis and COVID-19 Infection: A Case Report
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2022)

A case report of multiple sclerosis after COVID-19 infection: causality or coincidence?
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2021)

Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis
por: Behbehani, Raed, et al.
Publicado: (2017)

COVID-19 vaccination in people with multiple sclerosis, real-life experience
por: Alroughani, Raed, et al.
Publicado: (2022)

Non-parametric analysis of seasonality in birth and multiple sclerosis risk in second generation of migrants in Kuwait
por: Akhtar, Saeed, et al.
Publicado: (2014)

MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
por: Yamout, Bassem I, et al.
Publicado: (2021)

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait
por: Lamdhade, S., et al.
Publicado: (2014)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
por: Alroughani, Raed, et al.
Publicado: (2021)

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
por: Alroughani, R., et al.
Publicado: (2013)

ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility
por: Bourguiba-Hachemi, Sonia, et al.
Publicado: (2016)

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
por: Alroughani, Raed, et al.
Publicado: (2020)

Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East
por: Alroughani, Raed, et al.
Publicado: (2022)

Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
por: Achiron, Anat, et al.
Publicado: (2017)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East
por: Alroughani, Raed, et al.
Publicado: (2022)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Multiples sclerosis in India
por: Khadilkar, Satish V.
Publicado: (2015)

Multiple Sclerosis in India
por: Goyal, Vinay
Publicado: (2018)

Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria
por: Alroughani, R., et al.
Publicado: (2012)

An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
por: Alroughani, Raed, et al.
Publicado: (2019)

Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020)

Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring
por: Alroughani, Raed A, et al.
Publicado: (2014)

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective
por: Messina, Maria Josè, et al.
Publicado: (2015)

IL-11 in multiple sclerosis
por: Zhang, Xin, et al.
Publicado: (2015)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

Molecular Research in Multiple Sclerosis
por: Fucito, Maurine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eq05ea1ci83e174vg1nlj0srnj